Both CTL-1 and CD8+ effector cells exhibited higher expression of a T-cell exhaustion gene signature66–68 (Supplementary Data 4, Fig. 6c), and the exhaustion score was higher in the prostate tumor and adj-normal samples as compared to healthy prostate tissues (Fig. 6d). The gene discussed is SLC44A1; the disease is prostate neoplasm.